0001190725-16-000428.txt : 20160614 0001190725-16-000428.hdr.sgml : 20160614 20160614151615 ACCESSION NUMBER: 0001190725-16-000428 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160614 FILED AS OF DATE: 20160614 DATE AS OF CHANGE: 20160614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAUM CHARLES M CENTRAL INDEX KEY: 0001579824 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 161712875 MAIL ADDRESS: STREET 1: C/O MIRATI THERAPEUTICS INC. STREET 2: 9393 TOWNE CENTRE DRIVE, STE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2016-06-14 0 0001576263 Mirati Therapeutics, Inc. MRTX 0001579824 BAUM CHARLES M C/O MIRATI THERAPEUTICS INC. 9393 TOWNE CENTRE DRIVE, STE 200 SAN DIEGO CA 92121 1 1 0 0 PRESIDENT & CEO Common Stock 2016-06-14 4 P 0 20000 7.0535 A 48556 D The price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.96 to $7.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. /s/ Jamie A. Donadio, Attorney-in-Fact 2016-06-14